Laboratory Investigations for Disseminated Intravascular Coagulation

Introduction

  • Disseminated Intravascular Coagulation is a serious acquired disorder characterized by widespread activation of the coagulation system, resulting in excessive formation of microthrombi within blood vessels.
  • Continuous activation of coagulation pathways causes consumption of platelets and clotting factors, leading to simultaneous thrombosis and bleeding.

DIC is not a primary disease but occurs secondary to various clinical conditions such as:

  • Sepsis
  • Trauma
  • Malignancy
  • Obstetric complications
  • Severe infections
  • Massive tissue injury

Early laboratory diagnosis is essential because DIC can rapidly progress and become life-threatening.


Pathophysiology of DIC

Step 1: Initiation of Coagulation Cascade

DIC begins when large amounts of procoagulant substances enter the circulation.

Common triggers:

  • Sepsis
  • Trauma
  • Obstetric complications
  • Malignancy
  • Severe tissue injury

These conditions stimulate release of:

  • Tissue factor (TF)
  • Cytokines (TNF-α, IL-1, IL-6)
  • Procoagulant substances

Effect

  • Excessive activation of coagulation pathways

Step 2: Excessive Thrombin Generation

Activation of coagulation pathways results in excessive thrombin production.

Functions of thrombin:

  • Converts fibrinogen into fibrin
  • Activates platelets
  • Amplifies coagulation process

Result

  • Formation of widespread fibrin clots

Step 3: Formation of Microvascular Thrombi

Large amounts of fibrin are deposited within small blood vessels.

Effects

  • Formation of microthrombi in capillaries and arterioles
  • Obstruction of blood flow
  • Reduced tissue perfusion

Organs commonly affected:

  • Kidneys
  • Lungs
  • Liver
  • Brain
  • Heart

Step 4: Consumption of Platelets and Coagulation Factors

Continuous clot formation consumes:

  • Platelets
  • Fibrinogen
  • Prothrombin
  • Factor V
  • Factor VIII
  • Other clotting factors

Result

  • Progressive depletion of coagulation components

This phenomenon is called:

Consumption Coagulopathy


Step 5: Secondary Activation of Fibrinolysis

The body attempts to remove excessive fibrin deposition by activating fibrinolytic pathways.

Mechanism

Plasminogen is converted into plasmin.

Plasmin causes:

  • Breakdown of fibrin clots
  • Production of fibrin degradation products (FDPs)
  • Increased D-dimer formation

Result

  • Increased bleeding tendency

Step 6: Development of Bleeding

Because platelets and clotting factors become depleted:

Clinical manifestations include:

  • Petechiae
  • Ecchymosis
  • Mucosal bleeding
  • Hematuria
  • Gastrointestinal bleeding
  • Excessive surgical wound bleeding

Step 7: Organ Dysfunction and Failure

Microvascular thrombosis reduces blood flow to organs causing:

Organ complications

Kidneys

  • Acute kidney injury

Lungs

  • Respiratory distress

Brain

  • Neurological dysfunction

Liver

  • Hepatic dysfunction

Heart

  • Myocardial ischemia

Severe DIC may progress to:

  • Multiple organ failure
  • Shock
  • Death

Causes of DIC

The causes of DIC can be classified as follows:


1. Infectious Causes

Infections, particularly severe bacterial infections, are among the most common causes of DIC.

Examples

  • Septicemia (especially Gram-negative sepsis)
  • Severe bacterial infections
  • Viral infections
  • Fungal infections
  • Meningococcemia
  • Malaria

Mechanism

Microorganisms release toxins and inflammatory cytokines that stimulate tissue factor release and activate coagulation pathways.


2. Obstetric Causes

Obstetric complications commonly trigger DIC due to release of tissue thromboplastin into circulation.

Examples

  • Placental abruption
  • Amniotic fluid embolism
  • Retained dead fetus syndrome
  • Severe pre-eclampsia/eclampsia
  • Septic abortion
  • Postpartum hemorrhage

3. Malignancies

Certain cancers may activate coagulation mechanisms.

Examples

  • Acute promyelocytic leukemia (APL)
  • Metastatic adenocarcinoma
  • Pancreatic carcinoma
  • Prostate carcinoma

Mechanism

Tumor cells may produce procoagulant substances.


4. Trauma and Tissue Injury

Severe tissue damage releases tissue factors that activate coagulation.

Examples

  • Major trauma
  • Extensive burns
  • Head injury
  • Crush injuries
  • Major surgery

5. Hemolytic and Transfusion Reactions

Examples

  • Acute hemolytic transfusion reaction
  • Massive incompatible blood transfusion

Mechanism

Hemolysis releases procoagulant substances into circulation.


6. Vascular Disorders

Conditions affecting blood vessels may predispose to DIC.

Examples

  • Giant hemangioma (Kasabach-Merritt syndrome)
  • Aortic aneurysm
  • Vasculitis

7. Toxic and Miscellaneous Causes

Examples

  • Snake bite
  • Heat stroke
  • Acute pancreatitis
  • Shock
  • Severe liver disease

Laboratory Investigations 

Laboratory investigations are essential in the diagnosis of Disseminated Intravascular Coagulation because no single laboratory test confirms the disease. DIC diagnosis is based on a combination of abnormalities showing increased coagulation, platelet consumption, and enhanced fibrinolysis.

These investigations help in:

  • Early diagnosis
  • Assessment of severity
  • Monitoring progression
  • Evaluating treatment response

1. Complete Blood Count (CBC)

CBC is usually the initial test performed in suspected DIC patients.

Findings

  • Thrombocytopenia (decreased platelet count)
  • Reduced hemoglobin level due to bleeding or hemolysis
  • Mild leukocytosis may occur in infections

Significance

Platelets are continuously consumed during widespread clot formation, resulting in thrombocytopenia and increased bleeding tendency.


2. Platelet Count

Platelet count is one of the most important investigations in DIC.

Finding

  • Platelet count markedly decreased

Mechanism

Continuous intravascular clot formation consumes large numbers of circulating platelets.

Clinical Significance

  • Low platelet count indicates active consumption
  • Serial measurements help monitor progression

3. Peripheral Blood Smear Examination

Peripheral smear provides evidence of red blood cell damage.

Findings

  • Schistocytes (fragmented RBCs)
  • Helmet cells
  • Burr cells
  • Fragmented erythrocytes

Mechanism

Red blood cells passing through fibrin strands within vessels become mechanically damaged.

Clinical Significance

Presence of schistocytes indicates:

  • Microangiopathic hemolytic anemia
  • Active intravascular coagulation

4. Prothrombin Time (PT)

https://images.openai.com/static-rsc-4/nVnUbs3NrHusvSJ_h_QC03aQ17FATPjm95OSObcfmA3LkMQ6Lk1jye5TMUY4j7DelTFMINSkRue8U2rY89GfdjyD4a1_BUnYMhcmcT9JaAk7T4wYUrYQLn5YzHw34bYpYeHVLwIaDo-PPwZDFi9BGIjSgi9RM-9ssWzxHgC2CIYUvIsOm5GJXMBMi1uAFcp0?purpose=fullsize
PT measures the integrity of extrinsic and common coagulation pathways.

Factors assessed

  • Factor I (Fibrinogen)
  • Factor II (Prothrombin)
  • Factor V
  • Factor VII
  • Factor X

Findings

  • PT prolonged

Mechanism

Consumption of clotting factors due to ongoing coagulation activation.

Clinical Significance

  • Indicates coagulation factor depletion
  • Increased risk of bleeding

5. Activated Partial Thromboplastin Time (aPTT)

aPTT assesses intrinsic and common pathways.

Factors assessed

  • Factor VIII
  • Factor IX
  • Factor XI
  • Factor XII

Finding

  • aPTT prolonged

Mechanism

Consumption of intrinsic coagulation factors.

Clinical Significance

  • Helps evaluate severity of coagulation abnormalities

6. Thrombin Time (TT)

Thrombin time measures conversion of fibrinogen into fibrin.

Findings

  • Prolonged thrombin time

Mechanism

  • Reduced fibrinogen concentration
  • Interference by fibrin degradation products

Clinical Significance

Indicates impaired fibrin formation.


7. Plasma Fibrinogen Level

Fibrinogen is converted into fibrin during coagulation.

Finding

  • Reduced plasma fibrinogen level

Mechanism

Large amounts of fibrinogen are consumed for clot formation.

Clinical Significance

  • Indicates severe DIC
  • Associated with increased bleeding risk

8. D-Dimer Test

D-dimer is a specific fibrin degradation product formed after clot breakdown.

Finding

  • Markedly elevated D-dimer level

Mechanism

Excessive clot formation followed by fibrinolysis.

Clinical Significance

  • Highly sensitive indicator of DIC
  • Suggests active clot formation and breakdown

9. Fibrin Degradation Products (FDPs)

FDPs are produced during degradation of fibrin and fibrinogen.

Findings

  • Increased FDP level

Mechanism

Enhanced fibrinolysis results in excessive fibrin breakdown.

Clinical Significance

  • Supports diagnosis of DIC
  • Indicates increased fibrinolytic activity

10. Coagulation Factor Assays

Specific clotting factors may be measured.

Findings

Reduced levels of:

  • Factor V
  • Factor VIII
  • Factor XIII

Clinical Significance

Confirms consumption of coagulation proteins.


11. Antithrombin III Assay

Antithrombin III is a natural anticoagulant protein.

Finding

  • Reduced antithrombin III level

Mechanism

Consumption occurs during excessive coagulation activation.

Clinical Significance

  • Low levels indicate severe DIC
  • Associated with poor prognosis

12. ISTH DIC Scoring System

The International Society on Thrombosis and Haemostasis (ISTH) developed a scoring system for DIC.

Parameters included:

  • Platelet count
  • PT prolongation
  • Fibrinogen level
  • D-dimer/FDP levels

Significance

Helps:

  • Confirm diagnosis
  • Assess severity
  • Monitor treatment response

 

Scroll to Top
Enable Notifications OK No thanks